Up And Up Mint Nicotine Lozenge
Product Images NDC 82442-344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Up And Up Mint Nicotine (NDC 82442-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Wallet_card (Image 01)

Wallet_card (Image 01)
This text provides a list of important phone numbers for help related to health issues. It includes contact information for the American Lung Association, the American Cancer Society, and the American Heart Association. Additionally, it suggests reaching out to a "Quitting Buddy" or a friend who has successfully quit something, likely referring to support in quitting smoking.*
FDA Label Image

Wallet‑_card (Image 02)

Wallet‑_card (Image 02)
FDA Label Image

Smoke_free_logo (Image 03)

Smoke_free_logo (Image 03)
FDA Label Image

Upc_example (Image 04)

Upc_example (Image 04)
FDA Label Image

Stickers (Image 05)

Stickers (Image 05)
This text provides a schedule for using lozenges as a smoking cessation aid. It indicates the recommended frequency of lozenge intake at different stages of the quitting process, starting from Week #1 (quit date) up to 12 weeks after quitting. Users are advised to place reminders on their calendars to stay on track with the scheduled lozenge intake.*
FDA Label Image

344-uw-mint-nicotine-lozenge-1 (Image 06)

344-uw-mint-nicotine-lozenge-1 (Image 06)
This text provides information and tips for increasing success in quitting smoking, focusing on the use of Nicotine Polacrilex lozenges. It emphasizes the importance of motivation, using enough lozenges daily, using them for the full 12 weeks, and following a support program outlined in the User's Guide. It also compares the Mint Nicotine Lozenge to the active ingredient in Nicorette® Lozenge. Additionally, it specifies that the Nicotine Polacrilex Lozenge is for individuals who smoke their first cigarette more than 30 minutes after waking up, with a recommended dosage of 4 mg. The product mentioned includes 216 lozenges, each containing 2 mg of nicotine, with 8 containers containing 27 lozenges each. For more information and a free stop smoking program, individuals are directed to visit a specific website.*
FDA Label Image

344-uw-mint-nicotine-lozenge-2 (Image 07)

344-uw-mint-nicotine-lozenge-2 (Image 07)
This product is a nicotine lozenge designed to help individuals quit smoking. The lozenge contains 2mg of nicotine polacrilex per dosage, aimed at reducing withdrawal symptoms and cravings associated with quitting smoking. The packaging includes tamper-evident features for safety and instructions for proper usage. The product also offers a satisfaction guarantee. It is essential to read and follow the directions provided before using the lozenge. If you are under 18 years old, it is advised to consult with a doctor before using the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.